Funder: Society of Nuclear Medicine and Molecular Imaging
Due Dates (Anticipated): September 2027 (Application deadline)
Funding Amounts: $100,000
Summary: Supports nuclear medicine research on early detection of low- to intermediate-risk prostate cancer to improve patient management, survival, and quality of life.
Key Information: The principal investigator must be an active SNMMI member.
Description
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) offers this grant through its Mars Shot Research Fund to support nuclear medicine research focused on early detection of prostate cancer. The scientific scope is patients with low- to intermediate-risk disease: Grade Groups 1 and 2, corresponding to Gleason scores of 6 and 7 (3+4). The goal is to benefit patient management and potentially improve overall survival and quality of life.
The Mars Shot Research Fund supports translation of visionary nuclear medicine imaging, radiopharmaceutical therapy, and data science research into tools or treatments that improve patients’ lives. For this opportunity, reviewers consider relevance to the Mars Shot initiative, originality, scientific reasoning, methodology, and applicants’ ability to complete the proposed work.
